Alseres Pharmaceuticals, Inc.
Records under this name other than patents Alseres Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 8 of 8 · Back to Alseres Pharmaceuticals, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,986,653 | Labeled Iodinated Tropane Formulation Formerly held In force · Low confidence | In force | Low confidence | |
| US 9,757,483 | Labeled iodinated tropane formulation Formerly held In force · USPTO record | In force | USPTO record | |
| US 8,084,018 | Methods for Imaging Dopamine Transporter Level Formerly held In force · High confidence | In force | High confidence | |
| US 8,574,545 | Labeled iodinated tropane formulation Formerly held In force · USPTO record | In force | USPTO record | |
| US 6,936,437 | Methods and compositions for production of recombinant peptides Formerly held Lapsed on the fee record Ended Aug 30, 2017 · USPTO record | Lapsed on the fee record | Ended Aug 30, 2017 | USPTO record |
| US 8,133,861 | Systemic purine administration: modulating axonal outgrowth of central nervous system neurons Lapsed on the fee record Ended Mar 13, 2016 · USPTO record | Lapsed on the fee record | Ended Mar 13, 2016 | USPTO record |
| US 7,452,866 | Methods of Inhibiting Angiogenesis with Fragments and Homologs of Troponin Subunit 1 Lapsed on the fee record Ended Nov 18, 2012 · Medium confidence | Lapsed on the fee record | Ended Nov 18, 2012 | Medium confidence |
| US 5,344,924 | Solvent-free synthesis of ethereally substituted blocked monosaccharides and the selective hydrolysis thereof Term ended Term ended no later than Sep 6, 2014 · Low confidence | Term ended | Term ended no later than Sep 6, 2014 | Low confidence |